S'abonner

New indexes derived from routine blood tests and their clinical application in hepatocellular carcinoma - 24/11/22

Doi : 10.1016/j.clinre.2022.102043 
Qing-Qing Luo a, Ting Wang a, b, Kun-He Zhang a, b,
a Department of Gastroenterology, the First Affiliated Hospital of Nanchang University, Nanchang, China 
b Jiangxi Institute of Gastroenterology & Hepatology, Nanchang, China 

Corresponding author at: Department of Gastroenterology, the First Affiliated Hospital of Nanchang University, No 17, Yongwai Zheng Street, Nanchang, Jiangxi, 330006, China.Department of Gastroenterologythe First Affiliated Hospital of Nanchang UniversityNo 17, Yongwai Zheng StreetNanchangJiangxi330006China

Highlights

The occurrence of HCC can cause a series of local and systemic changes, which can be reflected in routine clinical indicators.
New indexes derived from routine blood tests integrate several clinical indicators into a new single indicator that can reflect the patient's disease situation more comprehensively.
Conventional clinical indicators are daily medical data that are easy to collect and economic, repeat, so the creation of new indicators based on the conventional tests can be carried out at all levels of medical centers.
Current evidence supports the use of derived indicator for the risk prediction, clinical diagnosis and prognostic evaluation of hepatocellular carcinoma.

Le texte complet de cet article est disponible en PDF.

Abstract

Considerable efforts have been made in the diagnosis and treatment of hepatocellular carcinoma (HCC), but the prognosis of patients with HCC remains poor. The development of officious and easy-to-use indicators that are applicable to all levels of hospitals for the diagnosis, prognosis and risk prediction of HCC may play an important role in improving the current undesirable situation. The occurrence of HCC can cause a series of local and systemic changes, involving liver function, inflammation, immunity, and nutrition, which can be reflected in routine clinical indicators, especially laboratory metrics. A comprehensive analysis of these routine indicators is capable of providing important information for the clinical management of HCC. Routine clinical indicators are daily medical data that are readily available, easily repeatable, and highly acceptable, which has attracted clinicians to derive a number of comprehensive indexes from routine clinical indicators by means of four arithmetic operations, scoring system, and mathematical modeling. These indexes integrate several clinical indicators into a new single indicator that performs better than any of original individual indicators in the risk prediction, clinical diagnosis and prognostic evaluation of HCC and is easy to use. Herein, we reviewed recent indexes derived from routine clinical indicators for the diagnosis, prognosis and risk prediction of HCC.

Le texte complet de cet article est disponible en PDF.

Keywords : Hepatocellular carcinoma, Derived indicator, Routine clinical indicator, Diagnosis, Prognosis

Abbreviations : PHC, HCC, AFP, ALT, AST, GGT, ALP, CRP, Fib, PA, Alb, APTT, SPDGFRβ, ANHCC, CLD, CHB, HBC, HBV-HCC, HBV-DNA, MELD, ALBI, NLR, PLR, SII, GPS, mGPS, Hs-mGPS, PI, PNI, LMR, LCR, FPR, FAR, GPR, CAR, ACR, APRI, FIB-4, LT, SR, RFA, TACE, HR, OR, OS, DFS, RFS, PRS, TTR, AUROC


Plan


© 2022  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 46 - N° 10

Article 102043- décembre 2022 Retour au numéro
Article précédent Article précédent
  • Solitary fibrous tumor of the liver with Doege-Potter syndrome: An exceptional finding. Discovering the role of blood glucose levels and insulin growth factor II
  • Francesco Taliente, Agostino Maria De Rose, Francesco Ardito, Felice Giuliante
| Article suivant Article suivant
  • Is it time for global adoption of endoscopic retrograde appendicitis therapy of acute appendicitis?
  • Saif Ullah, Faisal S. Ali, Miao Shi, Ji-Yu Zhang, Bing-Rong Liu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.